NT5E and ovarian cancer: Recent work demonstrated the internalization of MSC-derived exosomes by breast and ovarian cancer cells resulting in new tumor cell properties and functions by acquisition of MMP2 and ecto-5′-nucleotidase (CD73, a MSC surface marker) activity, respectively, enabling increased potential to reorganize the tumor microenvironment [139].